38325196|t|A natural small molecule aspidosperma-type alkaloid, hecubine, as a new TREM2 activator for alleviating lipopolysaccharide-induced neuroinflammation in vitro and in vivo.
38325196|a|Neuroinflammation and oxidative stress play a crucial role in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease. The triggering receptor expressed on myeloid cells 2 (TREM2), highly expressed by microglia in the central nervous system (CNS), can modulate neuroinflammatory responses. Currently, there are no approved drugs specifically targeting TREM2 for CNS diseases. Aspidosperma alkaloids have shown potential as anti-inflammatory and neuroprotective agents. This study aimed to elucidate the potential therapeutic effect of Hecubine, a natural aspidosperma-type alkaloid, as a TREM2 activator in lipopolysaccharide (LPS)-stimulated neuroinflammation in in vitro and in vivo models. In this study, molecular docking and cellular thermal shift assay (CTSA) were employed to investigate the interaction between Hecubine and TREM2. Enzyme-linked immunosorbent assay (ELISA), quantitative PCR, immunofluorescence, Western blotting, and shRNA gene knockdown were used to assess the anti-neuroinflammatory and antioxidant effects of Hecubine in microglial cells and zebrafish. Our results revealed that Hecubine directly interacted with TREM2, leading to its activation. Knockdown of TREM2 mRNA expression significantly abolished the anti-inflammatory and antioxidant effects of Hecubine on LPS-stimulated proinflammatory mediators (NO, TNF-alpha, IL-6, and IL-1beta) and oxidative stress in microglia cells. Furthermore, Hecubine upregulated Nrf2 expression levels while downregulating TLR4 signaling expression levels both in vivo and in vitro. Silencing TREM2 upregulated TLR4 and downregulated Nrf2 signaling pathways, mimicking the effect of Hecubine, further supporting TREM2 as the drug target by which Hecubine inhibits neuroinflammation. In conclusion, this is the first study to identify a small molecule, namely Hecubine directly targeting TREM2 to mediate anti-neuroinflammation and anti-oxidative effects, which serves as a potential therapeutic agent for the treatment of neural inflammation-associated CNS diseases.
38325196	25	51	aspidosperma-type alkaloid	Chemical	-
38325196	53	61	hecubine	Chemical	-
38325196	72	77	TREM2	Gene	101883794
38325196	104	122	lipopolysaccharide	Chemical	MESH:D008070
38325196	131	148	neuroinflammation	Disease	MESH:D000090862
38325196	171	188	Neuroinflammation	Disease	MESH:D000090862
38325196	253	279	neurodegenerative diseases	Disease	MESH:D019636
38325196	291	310	Alzheimer's disease	Disease	MESH:D000544
38325196	316	364	triggering receptor expressed on myeloid cells 2	Gene	101883794
38325196	366	371	TREM2	Gene	101883794
38325196	454	471	neuroinflammatory	Disease	MESH:D000090862
38325196	545	550	TREM2	Gene	101883794
38325196	555	567	CNS diseases	Disease	MESH:D002493
38325196	569	591	Aspidosperma alkaloids	Chemical	-
38325196	621	633	inflammatory	Disease	MESH:D007249
38325196	728	736	Hecubine	Chemical	-
38325196	748	774	aspidosperma-type alkaloid	Chemical	-
38325196	781	786	TREM2	Gene	101883794
38325196	800	818	lipopolysaccharide	Chemical	MESH:D008070
38325196	820	823	LPS	Chemical	MESH:D008070
38325196	836	853	neuroinflammation	Disease	MESH:D000090862
38325196	1012	1020	Hecubine	Chemical	-
38325196	1025	1030	TREM2	Gene	101883794
38325196	1185	1202	neuroinflammatory	Disease	MESH:D000090862
38325196	1230	1238	Hecubine	Chemical	-
38325196	1263	1272	zebrafish	Species	7955
38325196	1300	1308	Hecubine	Chemical	-
38325196	1334	1339	TREM2	Gene	101883794
38325196	1381	1386	TREM2	Gene	101883794
38325196	1436	1448	inflammatory	Disease	MESH:D007249
38325196	1476	1484	Hecubine	Chemical	-
38325196	1488	1491	LPS	Chemical	MESH:D008070
38325196	1503	1518	proinflammatory	Disease	
38325196	1534	1543	TNF-alpha	Gene	405785
38325196	1545	1549	IL-6	Gene	100885851
38325196	1555	1563	IL-1beta	Gene	405770
38325196	1619	1627	Hecubine	Chemical	-
38325196	1640	1644	Nrf2	Gene	360149
38325196	1754	1759	TREM2	Gene	101883794
38325196	1795	1799	Nrf2	Gene	360149
38325196	1844	1852	Hecubine	Chemical	-
38325196	1873	1878	TREM2	Gene	101883794
38325196	1907	1915	Hecubine	Chemical	-
38325196	1925	1942	neuroinflammation	Disease	MESH:D000090862
38325196	2020	2028	Hecubine	Chemical	-
38325196	2048	2053	TREM2	Gene	101883794
38325196	2070	2087	neuroinflammation	Disease	MESH:D000090862
38325196	2190	2202	inflammation	Disease	MESH:D007249
38325196	2214	2226	CNS diseases	Disease	MESH:D002493
38325196	Association	MESH:D002493	101883794
38325196	Association	MESH:D000090862	101883794
38325196	Positive_Correlation	101883794	405770
38325196	Positive_Correlation	101883794	360149
38325196	Positive_Correlation	100885851	101883794
38325196	Positive_Correlation	MESH:D008070	MESH:D000090862
38325196	Positive_Correlation	101883794	405785
38325196	Positive_Correlation	MESH:D008070	405770
38325196	Association	MESH:D008070	101883794
38325196	Association	MESH:D007249	101883794

